Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Early Initiation of Midodrine for Control and Prevention of Ascites and Its Related Complications in Acute-on-chronic Liver Failure: A Randomized Controlled Trial.
Conditions
Interventions
Midodrine
Standard Medical Treatment
Locations
1
India
Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, India
Start Date
February 5, 2026
Primary Completion Date
August 30, 2027
Completion Date
August 30, 2027
Last Updated
February 20, 2026
NCT06948565
NCT06340269
NCT06837766
NCT06285253
NCT06987968
NCT07276568
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions